GF-1003

N/A

Report date: 2025/05/16 17:35:43

Base Information

Drug NameGF-1003
Drug Alias NameGF-1003
ClassificationBiologics > ExosomesCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-6 modulators
TargetsNAD-dependent protein deacetylase sirtuin-6
Therapy Area/IndicationsWerner Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenflow Biosciences PLC
China Registration ClassN/A

Develop Information

Active CompaniesGenflow Biosciences PLC
Inactive CompaniesN/A
Active IndicationsWerner Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A